Diisobutylaluminumhydride → HCID 44555733, compound
Reaction equation
C([O:3][C:4]([C:6]1[C:7]([C:28]([F:31])([F:30])[F:29])=[N:8][N:9]([CH2:11][C:12]2[CH:13]=[C:14]3[C:18](=[CH:19][CH:20]=2)[CH:17]([NH:21][S:22]([CH:25]([CH3:27])[CH3:26])(=[O:24])=[O:23])[CH2:16][CH2:15]3)[CH:10]=1)=O)C.[H-].C([Al+]CC(C)C)C(C)C>C1COCC1>[OH:3][CH2:4][C:6]1[C:7]([C:28]([F:29])([F:31])[F:30])=[N:8][N:9]([CH2:11][C:12]2[CH:13]=[C:14]3[C:18](=[CH:19][CH:20]=2)[CH:17]([NH:21][S:22]([CH:25]([CH3:27])[CH3:26])(=[O:24])=[O:23])[CH2:16][CH2:15]3)[CH:10]=1Participants
Procedure
Ethyl-1-((1-(1-methylethylsulfonamido)-2,3-dihydro-1H-inden-5-yl)methyl)-3-(trifluoro methyl)-1H-pyrazole-4-carboxylate (0.196 mmol, 90 mg) was dissolved in THF (5 mL) and cooled in an ice bath under nitrogen. Di-isobutyl aluminium hydride (0.588 mmol, 0.588 mL) was added dropwise and the reaction stirred for 1.5 h. The reaction mixture was warmed to room temperature and stirred for a further 30 min before an additional 0.2 ml of di-isobutyl aluminium hydride was added and stirring continued for 30 min before quenching with MeOH followed by water. The mixture was concentrated before partitioning between EtOAc/water. The aq. layer was acidified with 5N HCl until all solids were in solution. The organic phase was collected, dried and concentrated and the residue purified by HPLC to give a colourless oil which crystallised on standing (63 mg, 0.151 mmol, 77%). 1H NMR (400 MHz, CDCl3) δ 1.43 (d, 6H) 1.95 (m, 1H) 2.65 (m, 1H) 2.80 (m, 1H) 3.00 (m, 1H), 3.24 (m, 1H) 4.20 (d, 1H) 4.65 (s, 2H) 4.95 (q, 1H) 5.28 (s, 2H) 7.13 (m, 2H) 7.44 (m, 2H).
Workup
- temperaturecooled in an ice bath under nitrogen
- additionwas added
- stirringstirring
- waitcontinued for 30 min
- custombefore quenching with MeOH
- concentrationThe mixture was concentrated
- custombefore partitioning between EtOAc/water
- customThe organic phase was collected
- customdried
- concentrationconcentrated
- customthe residue purified by HPLC
- customto give a colourless oil which
- customcrystallised
Sources & evidence
- ORD record
- ord-083afb9b493048899feed4c27e04c2c3
- Source dataset
- uspto-grants-2013_09
- Patent number
- US08536214B2
Reaction notes
Loading…